If you live in Arizona and are researching compounded GLP-1 medications, this page is meant to save you some digging. It explains how access works in the state, what Arizona law actually says about telehealth prescribing and about the pharmacies that compound and ship medication, what compounded semaglutide and tirzepatide cost, and how several providers serving Arizona compare on published cash prices. Everything here is drawn from public sources, with links, so you can check our work.
One disclosure up front: this site is operated by Gentle Health, a telehealth provider offering compounded GLP-1 treatment for weight management. Gentle Health appears in the comparison table below on the same terms as every other provider listed.
How compounded GLP-1 access works in Arizona
Arizona rebuilt its telehealth law in 2021 and ended up with one of the most telehealth-forward frameworks in the country. The state’s telehealth article (A.R.S. Title 36, Chapter 36, beginning at section 36-3601) says, in section 36-3602, that a regulatory board may not enforce any rule requiring an in-person examination before a provider issues a prescription, with the main exception being Schedule II controlled substances. A physical or mental health status examination “may be conducted during a telehealth encounter.” In plain terms: for a non-controlled medication like a GLP-1, a telehealth evaluation can stand on its own in Arizona.
Here is what that looks like in practice for a Gentle Health patient in Arizona:
- Complete a medical intake. You answer questions about your health history, current medications, and goals. This is the information a physician needs to decide whether a GLP-1 is appropriate for you.
- Physician review. Your intake is reviewed by James Simmons, MD, who holds an Arizona medical license (license 82062, state board record). Dr. Simmons evaluates every Arizona patient individually; not everyone who applies is approved.
- Prescription and fulfillment. If Dr. Simmons determines treatment is appropriate, the prescription is sent to a licensed compounding pharmacy, and the medication ships to your home anywhere in Arizona, from Yuma to the Navajo Nation.
- Ongoing care. Dosing is adjusted over time based on how you respond, and you can reach Dr. Simmons with questions between check-ins.
One Arizona-specific detail worth knowing: section 36-3602 requires your informed consent, verbal or written, before care is delivered through telehealth, and that consent becomes part of your medical record. It is a small step, but it is your cue that Arizona treats a telehealth visit as real medical care with real documentation, not a checkout flow.
Arizona rules worth knowing
Two bodies of Arizona law shape how compounded GLP-1s reach patients here: the telehealth article that governs prescribers, and the pharmacy permit rules that govern the pharmacies compounding and shipping the medication.
Telehealth prescribing. A few points from the telehealth article worth knowing:
- No in-person visit is required first. Under A.R.S. 36-3602(E), boards may not require an in-person examination before a prescription is issued, except for Schedule II drugs, which need an in-person or audio-visual examination. GLP-1 medications are not controlled substances, so the tighter rule does not apply to them.
- The standard of care does not move. Telehealth services remain subject to Arizona’s scope-of-practice laws and the best-practice guidelines adopted by the state’s telehealth advisory committee (36-3602(F)).
- Out-of-state clinicians can register rather than license. Under A.R.S. 36-3606, a provider licensed in another state may treat Arizona patients by telehealth after registering with the matching Arizona board, provided the home-state license is unrestricted and has no pending discipline. Registrants must carry liability insurance, consent to Arizona’s jurisdiction, follow Arizona’s standards of care, and report annually how many Arizona patients they served. They may not open an Arizona office or see Arizona patients in person. That framework is how some national telehealth companies operate here. It is not what Gentle Health relies on: Dr. Simmons holds a full Arizona license, which you can verify through the Arizona Medical Board’s search tool. Either way, the useful habit is the same, look the prescriber up before you sign up.
- If something goes wrong, venue is local. For registered out-of-state providers, 36-3606 sets venue for any civil or criminal action in the patient’s Arizona county of residence.
The pharmacy side. Arizona’s Board of Pharmacy permits every place of business that sells, compounds, or dispenses drugs in the state (A.R.S. 32-1930), and the rules follow the medication across state lines. Under Arizona Administrative Code R4-23-607, an out-of-state pharmacy may not ship prescription drugs to Arizona patients unless it holds both a current Board-issued nonresident pharmacy permit and an equivalent license in good standing from its home state. So whether your compounded medication is made in Phoenix or shipped in from elsewhere, an Arizona permit should sit behind it.
The federal backdrop. Under Section 503A of the Food, Drug and Cosmetic Act, pharmacies generally may not compound “drug products that are essentially copies of a commercially available drug product.” During the national shortages of semaglutide and tirzepatide products, those drugs were not considered commercially available, which opened the door to widespread compounding. The FDA has since declared both shortages resolved, semaglutide in a February 21, 2025 statement, and its enforcement grace periods for compounders ended in spring 2025. What remains on the market in 2026 is compounding for an individual patient under a valid prescription, where the compounded product is not an essential copy of a manufactured one. The ground can still shift: in April 2026, the FDA proposed removing semaglutide and tirzepatide from the list of bulk substances that 503B outsourcing facilities may use (Pharmacy Times coverage), a change that, if finalized, would further narrow how compounded GLP-1s can be made.
Arizona’s legislature has been circling this too. In the 2026 session, House Bill 4036 would have added a new section to the Board of Pharmacy’s statutes regulating compounding of GLP-1 receptor agonists and similar weight-management medications from bulk drug substances. It would have required pharmaceutical-grade ingredients from FDA-registered and inspected establishments, quality-control testing, two years of records, and specific disclosures in advertising, with civil penalties of $1,000 per dose for violations. The bill was withdrawn from committee before a vote (Frier Levitt’s analysis is a good summary), so none of that is law today. But it is a fair signal that Arizona lawmakers are watching this market, and the practices the bill described, ingredient sourcing, testing, documentation, are the right things to ask any provider about now.
None of this is a reason to avoid asking questions. It is a reason to ask more of them: who is prescribing, what pharmacy is compounding, and whether both are licensed, registered, or permitted for Arizona.
Compounded semaglutide in Arizona
Semaglutide is a GLP-1 receptor agonist. It works by mimicking a hormone your body already makes, one that signals fullness, slows how quickly your stomach empties, and helps regulate blood sugar. The practical effect most patients describe is that food quiets down: smaller portions satisfy, and the constant background negotiation with appetite eases.
Compounded semaglutide is prepared by a licensed compounding pharmacy for an individual patient, based on a prescription. It is not FDA-approved, which is a factual difference worth understanding, not a footnote: compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality before dispensing. Oversight comes instead from state pharmacy regulators, Arizona’s permit rules above being one example, and from the prescribing physician’s judgment about the individual patient. That is exactly why the questions about licensure and sourcing matter.
Gentle Health offers compounded semaglutide to Arizona patients in two forms, at dose-tiered cash prices:
- Oral semaglutide: starting at $112 per month. Taken daily, no needles involved.
- Injectable semaglutide: starting at $135 per month. A once-weekly subcutaneous injection with a small needle.
Both prices are cash-pay and dose-tiered; the monthly price changes if the prescribed dose moves into a different tier. Treatment is subject to medical evaluation by Dr. Simmons, and continuing care is included rather than billed separately.
Compounded tirzepatide in Arizona
Tirzepatide works on two hormone receptors rather than one: GLP-1 and GIP. Like semaglutide, it is prescribed for weight management alongside changes to eating and activity; the dual mechanism is the main pharmacological distinction between the two medications. Which one is appropriate for a given patient, if either, is a clinical decision, not a menu choice, and it depends on health history, other medications, and how a patient responds over time.
Compounded tirzepatide, like compounded semaglutide, is prepared for an individual patient by a licensed compounding pharmacy and is not FDA-approved.
Gentle Health offers compounded injectable tirzepatide to Arizona patients starting at $169 per month, cash-pay, priced according to the prescribed dose tier, once weekly. As with semaglutide, the evaluation, prescription decision, and ongoing dose adjustments are handled by James Simmons, MD.
Provider options in Arizona: comparison table
Methodology: rows are ordered alphabetically; prices were taken only from each provider’s public web pages on 2026-07-30, and where a provider does not publish a price we say “See site” rather than guessing. Gentle Health operates this site and is listed on the same terms as everyone else. We do not rank providers.
| Provider | Care model | Compounded semaglutide (cash/mo) | Compounded tirzepatide (cash/mo) | Serves Arizona | Insurance | Source |
|---|---|---|---|---|---|---|
| Eden | Telehealth; medication price plus separate membership ($39 first month, then $99/mo) | $99 + membership | $199 + membership | See site | Not required; HSA/FSA eligible | eden.health (verified 2026-07-30) |
| Gentle Health (operates this site) | Telehealth; care by James Simmons, MD; dose-tiered pricing, no separate membership fee | From $112 oral / from $135 injectable | From $169 | Yes | No insurance; cash-pay only | gentle.health (verified 2026-07-30) |
| Medi-Weightloss (Tucson) | In-person clinic on North Oracle Road; program visits, some insurance accepted; membership plans from $199/mo plus $199 new-patient visit | $99 first month (offer); ongoing See site | $199 first month (offer); ongoing See site | Yes (Tucson clinic; also serves Marana, Oro Valley, Sahuarita, Vail) | Contracted with some carriers for program visits; many patients pay $0-$50 per visit per its page | mediweightloss.com (verified 2026-07-30) |
| Mochi Health | Telehealth; medication price plus $79/mo membership | $99 + membership | $199 + membership | Yes (serves all US states per its FAQ) | See site | joinmochi.com (verified 2026-07-30) |
| Tucson Wellness MD | In-person clinics (Tucson, Oro Valley, Marana, Vail); programs from $230/mo with consultation and body composition assessment | From $175 per four injections | From $225 per four treatments | Yes (four Tucson-area locations) | Varies by plan; see site | tucsonwellnessmd.com (verified 2026-07-30) |
| Valley Medical Weight Loss | In-person clinics (Phoenix, Tempe, Chandler, Glendale); same-day walk-in consultations | See site (GLP-1 programs advertised from $99) | From about $50/week (as published) | Yes (four Phoenix-area locations) | See site | valleymedicalweightloss.com (verified 2026-07-30) |
A few reading notes. Headline medication prices and total monthly cost are not the same thing: where a provider charges a separate membership or program fee, your real monthly outlay is the sum of the two lines, and per-week or per-four-treatment prices need multiplying out before you compare them to a monthly price. Tucson Wellness MD’s page publishes two starting figures for each medication (per four treatments and per month); the table uses the four-treatment figures, so check the site for how your plan would actually bill. First-month offers are common in this market, Arizona included, so it is worth checking what month four costs, not just month one. And every provider on this list requires a medical evaluation; a price is only relevant if a licensed prescriber determines treatment is appropriate for you.
Frequently asked questions: compounded GLP-1 in Arizona
Is compounded semaglutide legal in Arizona? Compounding for an individual patient under a valid prescription is legal under federal law (Section 503A) and Arizona law when the pharmacy holds the right Board of Pharmacy permit and the compounded product is not an essential copy of a commercially available drug. Since the FDA declared the semaglutide and tirzepatide shortages resolved in 2025, compounding copies of the approved products is no longer permitted, so what remains available are individualized formulations prescribed for specific patients. An Arizona bill that would have added state-level sourcing and testing requirements for compounded GLP-1s, HB 4036, was withdrawn in the 2026 session, but the area remains under active regulatory attention.
Do I need an in-person doctor visit to get a GLP-1 prescription in Arizona? No. Under A.R.S. 36-3602, Arizona boards may not require an in-person examination before a prescription is issued, except for Schedule II controlled substances. GLP-1 medications are not controlled substances, so a telehealth evaluation is sufficient if the prescriber determines treatment is appropriate. You will be asked for informed consent before the telehealth visit, which the statute requires.
Who prescribes for Gentle Health patients in Arizona? James Simmons, MD, who holds an Arizona medical license (license 82062). You can confirm the license through the Arizona Medical Board’s verification search. Every prescription decision at Gentle Health is made by Dr. Simmons based on an individual medical evaluation.
How can I check whether an online provider is allowed to treat patients in Arizona? Two lookups cover it. For the prescriber: search the Arizona Medical Board’s verification tool for a full Arizona license, and remember that Arizona also lets out-of-state clinicians register with the matching Arizona board under A.R.S. 36-3606 instead of licensing, so ask which arrangement applies. For the pharmacy: it should hold an Arizona pharmacy permit or, if out of state, a Board-issued nonresident pharmacy permit plus its home-state license. A provider should be able to tell you plainly which pharmacy fills its Arizona prescriptions.
Does insurance cover compounded GLP-1s in Arizona? Generally, no. Insurance plans typically do not cover compounded medications, and most telehealth providers in this market, Gentle Health included, are cash-pay. Some accept HSA or FSA funds, and some in-person clinics bill insurance for program visits even though the compounded medication itself is cash-pay; check the individual provider’s site.
How does the medication get to me, and does Arizona heat matter? After a prescription is issued, a licensed compounding pharmacy prepares your medication and ships it to your address in Arizona. Out-of-state pharmacies shipping into Arizona must hold a Board-issued nonresident pharmacy permit under R4-23-607. Shipments are packaged for temperature control where the formulation requires it, which is a fair thing to ask any provider about before a Phoenix summer delivery: how the medication is insulated, and what happens if a shipment arrives compromised.
Can I get compounded GLP-1 treatment anywhere in Arizona, or only in Phoenix and Tucson? Anywhere in the state. Because the model is telehealth plus home delivery, a patient in Kingman, Show Low, or Douglas has the same access as a patient in Phoenix, Tucson, or Flagstaff. That is arguably where telehealth earns its keep in Arizona: the in-person options in the table above cluster in the two big metros, while much of the state lives hours from either. If you would rather begin from a page written for your own city, we keep them for Tempe, Gilbert and Phoenix, and the full Arizona plan details are on our state page. The program is the same in all of them; only the shipping address changes.
Current Gentle Health dose tiers and pricing
Gentle Health pricing depends on the dose tier prescribed by your clinician. Current monthly prices are:
Oral compounded semaglutide
| Tier | Daily dose | Monthly price |
|---|---|---|
| Starting | 2-4 mg/day | $112/mo |
| Medium | >4-8 mg/day | $189/mo |
| High dose | >8-12 mg/day | $258/mo |
Injectable compounded semaglutide
| Tier | Weekly dose | Monthly price |
|---|---|---|
| Starting | 0.24-0.48 mg/wk | $135/mo |
| Medium | >0.48-1.2 mg/wk | $159/mo |
| High dose | >1.2-2.4 mg/wk | $199/mo |
Injectable compounded tirzepatide
| Tier | Weekly dose | Monthly price |
|---|---|---|
| Starting | 2.5-5 mg/wk | $169/mo |
| Medium | >5-10 mg/wk | $219/mo |
| High dose | >10-15 mg/wk | $269/mo |
Medication, the initial review by a licensed clinician, video visits and messaging, and overnight refrigerated shipping are included. There is no separate membership fee, and HSA and FSA cards are accepted. Your clinician determines the appropriate medication and dose; the monthly price changes if the prescribed dose moves into a different tier.
Gentle Health serves patients across a growing multistate footprint through clinicians licensed in each patient’s jurisdiction, including Arizona.
Reviewed by James Simmons, MD
Compounded medications are not FDA-approved. Treatment subject to medical evaluation.